| # | Drug | Count |
|---|---|---|
| 0 | LENALIDOMIDE | 30 |
| 1 | CYCLOPHOSPHAMIDE | 18 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 18 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 18 |
| 4 | DEXAMETHASONE | 15 |
| 5 | DEXAMETHASONE 1.5 MG | 15 |
| 6 | PANTOPRAZOLE | 11 |
| 7 | CARBOPLATIN | 10 |
| 8 | DOXORUBICIN | 10 |
| 9 | POMALIDOMIDE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IDECABTAGENE VICLEUCEL | 3 | 0.0024 |
| 1 | LOMUSTINE | 3 | 0.0012 |
| 2 | CHLORAMBUCIL | 4 | 0.0010 |
| 3 | CILTACABTAGENE AUTOLEUCEL | 4 | 0.0006 |
| 4 | IVOSIDENIB | 1 | 0.0005 |
| 5 | SELINEXOR | 4 | 0.0005 |
| 6 | DACTINOMYCIN | 1 | 0.0005 |
| 7 | OLAPARIB | 9 | 0.0004 |
| 8 | CABAZITAXEL | 1 | 0.0003 |
| 9 | BRIGATINIB | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Thalidomide Analog [EPC] | 30 |
| 1 | Alkylating Drug [EPC] | 22 |
| 2 | Corticosteroid [EPC] | 18 |
| 3 | Platinum-based Drug [EPC] | 13 |
| 4 | Microtubule Inhibitor [EPC] | 11 |
| 5 | Kinase Inhibitor [EPC] | 10 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 10 |
| 7 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 9 |
| 8 | Proteasome Inhibitor [EPC] | 9 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 1 | Nuclear Export Inhibitor [EPC] | 4 | 0.0005 |
| 2 | Actinomycin [EPC] | 1 | 0.0005 |
| 3 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 9 | 0.0004 |
| 4 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 1 | 0.0002 |
| 5 | BCL-2 Inhibitor [EPC] | 7 | 0.0001 |
| 6 | Alkylating Drug [EPC] | 22 | 0.0001 |
| 7 | Proteasome Inhibitor [EPC] | 9 | 0.0001 |
| 8 | Microtubule Inhibitor [EPC] | 11 | 0.0001 |
| 9 | Thalidomide Analog [EPC] | 30 | 0.0001 |